Capecitabine monotherapy for elderly patients with metastatic breast cancer.

被引：0
|
作者：
Minea, LN [1 ]
Stanculeanu, DL [1 ]
Cringeanu, A [1 ]
Anghel, RM [1 ]
机构：
[1] Inst Oncol Bucharest, Bucharest, Romania
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
797
引用
收藏
页码：76S / 76S
页数：1
相关论文
共 50 条
  • [21] Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.
    Altundag, Kadri
    Babacan, Taner
    Efe, Orhan
    Hasirci, Ahmet S.
    Demirci, Fatih
    Buyukhatipoglu, Hakan
    Balakan, Ozan
    Sarici, Furkan Saim
    Kertmen, Neyran
    Esin, Ece
    Akin, Serkan
    Ates, Ozturk
    Aksoy, Sercan
    Sever, Ali R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Efficacy and tolerability of capecitabine (X) monotherapy in metastatic breast cancer (MBC)
    Vasev, Nikola
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [23] Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer
    Crown, John P.
    Dieras, Veronique
    Staroslawska, Elzbieta
    Yardley, Denise A.
    Bachelot, Thomas
    Davidson, Neville
    Wildiers, Hans
    Fasching, Peter A.
    Capitain, Olivier
    Ramos, Manuel
    Greil, Richard
    Cognetti, Francesco
    Fountzilas, George
    Blasinska-Morawiec, Maria
    Liedtke, Cornelia
    Kreienberg, Rolf
    Miller, Wilson H., Jr.
    Tassell, Vanessa
    Huang, Xin
    Paolini, Jolanda
    Kern, Kenneth A.
    Romieu, Gilles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2870 - +
  • [24] Intermittent capecitabine monotherapy with lower dose intensity in heavily pretreated patients with metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Iwase, Takuji
    Hatake, Kiyohiko
    TUMORI, 2007, 93 (02) : 129 - 132
  • [25] Capecitabine Monotherapy is Efficient and Safe in All Line Settings in Patients with Metastatic and Advanced Breast Cancer
    Amari, Masakazu
    Ishida, Takanori
    Takeda, Motohiro
    Ohuchi, Noriaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 188 - 193
  • [26] Impact of absolute lymphocyte count on the efficacy of eribulin and capecitabine in patients with metastatic breast cancer.
    Ueno, Ayako
    Maeda, Reina
    Kim, Kyeongduk
    Ito, Mitsuya
    Kawasaki, Kensuke
    Ohtani, Shoichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC).
    Zamora, P
    de Mon, MA
    Calvo, L
    Jara, C
    Virizuela, JA
    Yubero, A
    Chacón, JI
    Mira, J
    Barón, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [28] Metastatic breast cancer and pregnancy - a successful pregnancy outcome following Capecitabine monotherapy
    Liu, B.
    Hutt, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 : 96 - 96
  • [29] Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
    Knudsen, Anne-Dorthe Mosgaard
    Modvig, Mikala Wej
    Vogsen, Marianne
    Kodahl, Annette Raskov
    MEDICAL ONCOLOGY, 2024, 41 (05)
  • [30] Fixed dose, dose-dense capecitabine in metastatic breast cancer.
    O'Dea, Anne
    Khan, Meshaal
    Haines, Haley Isabela
    Kimler, Bruce F.
    Nye, Lauren Elizabeth
    Sharma, Priyanka
    Khan, Qamar J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345